Page last updated: 2024-10-31

metoclopramide and Brain Concussion

metoclopramide has been researched along with Brain Concussion in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Brain Concussion: A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McBeath, JG1
Nanda, A1

Other Studies

1 other study available for metoclopramide and Brain Concussion

ArticleYear
Use of dihydroergotamine in patients with postconcussion syndrome.
    Headache, 1994, Volume: 34, Issue:3

    Topics: Adult; Brain Concussion; Dihydroergotamine; Drug Therapy, Combination; Female; Headache; Humans; Mal

1994